Furthermore, we also indicated that cAMP/PKA may act as a negative feedback regulator of ER stress-induced NLRP3 inflammasome activation, thereby inhibiting type II AEC pyroptosis and eventually alleviating pulmonary fibrosis. The gene discussed is NLRP3; the disease is pulmonary fibrosis.